Gamma Investing LLC Akero Therapeutics, Inc. Transaction History
Gamma Investing LLC
- $1.17 Trillion
- Q4 2024
A detailed history of Gamma Investing LLC transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 133 shares of AKRO stock, worth $5,757. This represents 0.0% of its overall portfolio holdings.
Number of Shares
133
Previous 119
11.76%
Holding current value
$5,757
Previous $3.41 Million
8.38%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding AKRO
# of Institutions
209Shares Held
66.9MCall Options Held
321KPut Options Held
558K-
Rtw Investments, LP New York, NY6.86MShares$297 Million3.11% of portfolio
-
Janus Henderson Group PLC London, X06.03MShares$261 Million0.09% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$242 Million0.0% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$227 Million5.21% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.32MShares$187 Million0.01% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $2.01B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...